DC Investment Partners

Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.

Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapeutics that enhance the body’s immune response to cancer. Founded in 2017, the company utilizes its proprietary PREDATOR platform to engineer conditionally activated molecules, known as INDUKINE molecules. These therapeutics are designed to remain inactive in peripheral tissues but activate selectively within the tumor microenvironment, addressing the limitations of traditional proinflammatory immune therapies. By stimulating both adaptive and innate immunity, Werewolf Therapeutics aims to improve cancer treatment outcomes.

Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.